Product Information
PANTOPRAZOLE SOD DR 40 MG TAB is a generic product labeled by Burel Pharmaceuticals, LLC, priced at $0.0358 per EA under NDC 35573042880. Its NADAC has been published 315 times since Sep 23, 2020.
FDA first approved this application on Sep 28, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Burel Pharmaceuticals, LLCNDC
35573042880
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PANTOPRAZOLE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA202038FDA Approved
9/28/2012
TE Code
AB
On Market Since
4/20/2020
Pharmacological Classes
Price Statistics
The NADAC for PANTOPRAZOLE SOD DR 40 MG TAB has been published 315 times since Sep 23, 2020, and over the history we have for it it has declined 41.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0358 per EA |
|---|---|
| All-time high | $0.0675 (May 12, 2021) |
| All-time low | $0.0331 (Nov 20, 2024) |
| 52-week high | $0.0371 |
| 52-week low | $0.0352 |
| Median price | $0.0553 |
| Average price | $0.0513 |
| Largest weekly change | -39.6% (Nov 20, 2024) |
| Weeks tracked | 315 |
| Tracking since | Sep 23, 2020 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Burel Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pantoprazole Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PANTOPRAZOLE SOD DR 40 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PANTOPRAZOLE SOD DR 40 MG TAB, manufactured by Burel Pharmaceuticals, LLC, is $0.0358 per EA (NDC 35573042880), effective Sep 30, 2026.
How has the price of PANTOPRAZOLE SOD DR 40 MG TAB changed over time?
Over the history we have for it, the NADAC for PANTOPRAZOLE SOD DR 40 MG TAB has declined 41.2%. It has been tracked across 315 weekly CMS publications since Sep 23, 2020.
What are the highest and lowest recorded NADAC prices for PANTOPRAZOLE SOD DR 40 MG TAB?
Since Sep 23, 2020, the NADAC for PANTOPRAZOLE SOD DR 40 MG TAB has ranged from a low of $0.0331 (Nov 20, 2024) to a high of $0.0675 (May 12, 2021), with a median of $0.0553 per EA.
Are there cheaper alternatives to PANTOPRAZOLE SOD DR 40 MG TAB?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PANTOPRAZOLE SOD DR 40 MG TAB, is $0.0354 per EA — about 1% below PANTOPRAZOLE SOD DR 40 MG TAB.
Who manufactures PANTOPRAZOLE SOD DR 40 MG TAB?
PANTOPRAZOLE SOD DR 40 MG TAB (NDC 35573042880) is labeled by Burel Pharmaceuticals, LLC, and CMS classifies it as a generic product.